Summary
CVS Health Corporation (CVS) has announced the issuance and sale of $1 billion in 2.125% Senior Notes due 2031. This debt offering, finalized through an Underwriting Agreement on August 9, 2021, is expected to close on August 18, 2021. The net proceeds to CVS Health are approximately $987 million, which will be utilized for general corporate purposes. This action indicates CVS Health's strategy to manage its capital structure and potentially fund ongoing operations or strategic initiatives. Investors should note the terms of the debt, including the interest rate and maturity date, as well as the effective cost of capital after expenses. The company is leveraging its existing shelf registration statement for this issuance.
Key Highlights
- 1CVS Health issued $1 billion in 2.125% Senior Notes due 2031.
- 2The Underwriting Agreement was entered into on August 9, 2021.
- 3The offering is expected to close on August 18, 2021.
- 4Net proceeds from the sale are estimated to be approximately $987 million.
- 5Proceeds are intended for general corporate purposes.
- 6The notes were offered under the company's existing Form S-3ASR registration statement.
Frequently Asked Questions
The company has stated that the net proceeds from the sale of the notes are intended for general corporate purposes. This could include funding operations, strategic investments, or refinancing existing debt.
The closing of the sale of the notes is expected to occur on August 18, 2021, subject to customary closing conditions.
The notes being issued are 2.125% Senior Notes due 2031, meaning they mature in 2031 and carry a fixed interest rate of 2.125% per annum.
After deducting underwriters' discounts and estimated offering expenses, CVS Health expects to receive approximately $987,162,000 from the sale of the $1 billion principal amount of notes.